{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:48:01Z","timestamp":1768254481679,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,26]]},"DOI":"10.7759\/cureus.79693","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T14:57:31Z","timestamp":1740581851000},"source":"Crossref","is-referenced-by-count":1,"title":["Emerging Novel Therapies for the Treatment of Psoriasis: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Alan D","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille  B","family":"Coreil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lane  S","family":"Amedio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria  A","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy  N","family":"Vu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anusha","family":"Kallurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor  W","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Psoriasis","author":"Nair PA","year":"2024","unstructured":"Nair PA, Badri T. Psoriasis. StatPearls Publishing, Treasure Island; 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong AW","year":"2021","unstructured":"Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CE. Psoriasis prevalence in adults in the United States. JAMA Dermatol. 2021, 157:940-946. 10.1001\/jamadermatol.2021.2007","journal-title":"JAMA Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja A","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021, 21:170-173. 10.7861\/clinmed.2021-0257","journal-title":"Clin Med (Lond)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon A","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019, 20:1475. 10.3390\/ijms20061475","journal-title":"Int J Mol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.993057","article-title":"Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review","volume":"14","author":"Wang J","year":"2023","unstructured":"Wang J, Wang C, Liu L, et al.. Adverse events associated with anti-IL-17 agents for psoriasis and psoriatic arthritis: a systematic scoping review. Front Immunol. 2023, 14:993057. 10.3389\/fimmu.2023.993057","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01865","article-title":"IL-21 induces an imbalance of Th17\/Treg cells in moderate-to-severe plaque psoriasis patients","volume":"10","author":"Shi Y","year":"2019","unstructured":"Shi Y, Chen Z, Zhao Z, et al.. IL-21 induces an imbalance of Th17\/Treg cells in moderate-to-severe plaque psoriasis patients. Front Immunol. 2019, 10:1865. 10.3389\/fimmu.2019.01865","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S462797","article-title":"The role of interleukin 23\/17 axis in psoriasis management: a comprehensive review of clinical trials","volume":"17","author":"Potestio L","year":"2024","unstructured":"Potestio L, Martora F, Lauletta G, Vallone Y, Battista T, Megna M. The role of interleukin 23\/17 axis in psoriasis management: a comprehensive review of clinical trials. Clin Cosmet Investig Dermatol. 2024, 17:829-842. 10.2147\/CCID.S462797","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-024-01300-7","article-title":"Small nucleolar RNA Snora73 promotes psoriasis progression by sponging miR-3074-5p and regulating PBX1 expression","volume":"24","author":"Zhang L","year":"2024","unstructured":"Zhang L, Guo H, Zhang X, et al.. Small nucleolar RNA Snora73 promotes psoriasis progression by sponging miR-3074-5p and regulating PBX1 expression. Funct Integr Genomics. 2024, 24:15. 10.1007\/s10142-024-01300-7","journal-title":"Funct Integr Genomics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/nu14142970","article-title":"Gut microbiota in psoriasis","volume":"14","author":"Buha\u0219 MC","year":"2022","unstructured":"Buha\u0219 MC, Gavrila\u0219 LI, Candrea R, C\u0103tinean A, Mocan A, Miere D, T\u0103taru A. Gut microbiota in psoriasis. Nutrients. 2022, 14:2970. 10.3390\/nu14142970","journal-title":"Nutrients"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116068","article-title":"Natural product-derived compounds targeting keratinocytes and molecular pathways in psoriasis therapeutics","volume":"25","author":"Lee YG","year":"2024","unstructured":"Lee YG, Jung Y, Choi HK, Lee JI, Lim TG, Lee J. Natural product-derived compounds targeting keratinocytes and molecular pathways in psoriasis therapeutics. Int J Mol Sci. 2024, 25:10.3390\/ijms25116068","journal-title":"Int J Mol Sci"},{"key":"ref11","article-title":"Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells","volume":"8","author":"Wang Y","year":"2016","unstructured":"Wang Y, Wang LL, Yang HY, Wang FF, Zhang XX, Bai YP. Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells. Am J Transl Res. 2016, 8:3188-3196.","journal-title":"Am J Transl Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211236","article-title":"Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy","volume":"14","author":"Varkey R","year":"2019","unstructured":"Varkey R, Du Q, Karnell JL, et al.. Discovery and characterization of potent IL-21 neutralizing antibodies via a novel alternating antigen immunization and humanization strategy. PLoS One. 2019, 14:e0211236. 10.1371\/journal.pone.0211236","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102689","article-title":"New developments implicating IL-21 in autoimmune disease","volume":"122","author":"Ren HM","year":"2021","unstructured":"Ren HM, Lukacher AE, Rahman ZS, Olsen NJ. New developments implicating IL-21 in autoimmune disease. J Autoimmun. 2021, 122:102689. 10.1016\/j.jaut.2021.102689","journal-title":"J Autoimmun"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nature07021","article-title":"IL-21 and TGF-beta are required for differentiation of human T(H)17 cells","volume":"454","author":"Yang L","year":"2008","unstructured":"Yang L, Anderson DE, Baecher-Allan C, et al.. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature. 2008, 454:350-352. 10.1038\/nature07021","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz1140","article-title":"Functional diversity of small nucleolar RNAs","volume":"48","author":"Bratkovi\u010d T","year":"2020","unstructured":"Bratkovi\u010d T, Bo\u017ei\u010d J, Rogelj B. Functional diversity of small nucleolar RNAs. Nucleic Acids Res. 2020, 48:1627-1651. 10.1093\/nar\/gkz1140","journal-title":"Nucleic Acids Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.82","article-title":"Psoriasis","volume":"2","author":"Greb JE","year":"2016","unstructured":"Greb JE, Goldminz AM, Elder JT, et al.. Psoriasis. Nat Rev Dis Primers. 2016, 2:16082. 10.1038\/nrdp.2016.82","journal-title":"Nat Rev Dis Primers"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1430586","article-title":"Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions","volume":"14","author":"Zou X","year":"2024","unstructured":"Zou X, Zou X, Gao L, Zhao H. Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions. Front Cell Infect Microbiol. 2024, 14:1430586. 10.3389\/fcimb.2024.1430586","journal-title":"Front Cell Infect Microbiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1344963","article-title":"IL-17A inhibitors alleviate psoriasis with concomitant restoration of intestinal\/skin microbiota homeostasis and altered microbiota function","volume":"15","author":"Zhao H","year":"2024","unstructured":"Zhao H, Shang L, Zhang Y, et al.. IL-17A inhibitors alleviate psoriasis with concomitant restoration of intestinal\/skin microbiota homeostasis and altered microbiota function. Front Immunol. 2024, 15:1344963. 10.3389\/fimmu.2024.1344963","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.903160","article-title":"Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms","volume":"13","author":"Zhang S","year":"2022","unstructured":"Zhang S, Wang J, Liu L, et al.. Efficacy and safety of curcumin in psoriasis: preclinical and clinical evidence and possible mechanisms. Front Pharmacol. 2022, 13:903160. 10.3389\/fphar.2022.903160","journal-title":"Front Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fochms.2024.100198","article-title":"Curcumin as a regulator of Th17 cells: unveiling the mechanisms","volume":"8","author":"Ghoushi E","year":"2024","unstructured":"Ghoushi E, Poudineh M, Parsamanesh N, Jamialahmadi T, Sahebkar A. Curcumin as a regulator of Th17 cells: unveiling the mechanisms. Food Chem (Oxf). 2024, 8:100198. 10.1016\/j.fochms.2024.100198","journal-title":"Food Chem (Oxf)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.8217","article-title":"Luteolin: a promising multifunctional natural flavonoid for human diseases","volume":"38","author":"Zhu M","year":"2024","unstructured":"Zhu M, Sun Y, Su Y, et al.. Luteolin: a promising multifunctional natural flavonoid for human diseases. Phytother Res. 2024, 38:3417-3443. 10.1002\/ptr.8217","journal-title":"Phytother Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110221","article-title":"Piperine ameliorates psoriatic skin inflammation by inhibiting the phosphorylation of STAT3","volume":"119","author":"Lu H","year":"2023","unstructured":"Lu H, Gong H, Du J, et al.. Piperine ameliorates psoriatic skin inflammation by inhibiting the phosphorylation of STAT3. Int Immunopharmacol. 2023, 119:110221. 10.1016\/j.intimp.2023.110221","journal-title":"Int Immunopharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29092007","article-title":"Pharmacological potential of kaempferol, a flavonoid in the management of pathogenesis via modulation of inflammation and other biological activities","volume":"29","author":"Alrumaihi F","year":"2024","unstructured":"Alrumaihi F, Almatroodi SA, Alharbi HO, Alwanian WM, Alharbi FA, Almatroudi A, Rahmani AH. Pharmacological potential of kaempferol, a flavonoid in the management of pathogenesis via modulation of inflammation and other biological activities. Molecules. 2024, 29:10.3390\/molecules29092007","journal-title":"Molecules"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104463","article-title":"Pharmacological properties and derivatives of shikonin \u2014\u00a0a review in recent years","volume":"149","author":"Guo C","year":"2019","unstructured":"Guo C, He J, Song X, et al.. Pharmacological properties and derivatives of shikonin \u2014\u00a0a review in recent years. Pharmacol Res. 2019, 149:104463. 10.1016\/j.phrs.2019.104463","journal-title":"Pharmacol Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11010029","article-title":"Punicalagin regulates signaling pathways in inflammation-associated chronic diseases","volume":"11","author":"Xu J","year":"2021","unstructured":"Xu J, Cao K, Liu X, Zhao L, Feng Z, Liu J. Punicalagin regulates signaling pathways in inflammation-associated chronic diseases. Antioxidants (Basel). 2021, 11:29. 10.3390\/antiox11010029","journal-title":"Antioxidants (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.820969","article-title":"Genistein: a review on its anti-inflammatory properties","volume":"13","author":"Goh YX","year":"2022","unstructured":"Goh YX, Jalil J, Lam KW, Husain K, Premakumar CM. Genistein: a review on its anti-inflammatory properties. Front Pharmacol. 2022, 13:820969. 10.3389\/fphar.2022.820969","journal-title":"Front Pharmacol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.967","article-title":"Curcumin alleviates imiquimod-induced psoriasis-like inflammation and regulates gut microbiota of mice","volume":"11","author":"Cai Z","year":"2023","unstructured":"Cai Z, Wang W, Zhang Y, Zeng Y. Curcumin alleviates imiquimod-induced psoriasis-like inflammation and regulates gut microbiota of mice. Immun Inflamm Dis. 2023, 11:e967. 10.1002\/iid3.967","journal-title":"Immun Inflamm Dis"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102393","article-title":"Food components and dietary habits: keys for a healthy gut microbiota composition","volume":"11","author":"Rinninella E","year":"2019","unstructured":"Rinninella E, Cintoni M, Raoul P, et al.. Food components and dietary habits: keys for a healthy gut microbiota composition. Nutrients. 2019, 11:2393. 10.3390\/nu11102393","journal-title":"Nutrients"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10020328","article-title":"Polyphenols in the Mediterranean diet: from dietary sources to microRNA modulation","volume":"10","author":"Cannataro R","year":"2021","unstructured":"Cannataro R, Fazio A, La Torre C, Caroleo MC, Cione E. Polyphenols in the Mediterranean diet: from dietary sources to microRNA modulation. Antioxidants (Basel). 2021, 10:328. 10.3390\/antiox10020328","journal-title":"Antioxidants (Basel)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70049","article-title":"Adherence to the Mediterranean diet in patients with psoriasis and its relationship with the severity of the disease: a case-control study","volume":"7","author":"Aryanian Z","year":"2024","unstructured":"Aryanian Z, Asghari M, Zanousi PP, Ghadimi R, Kebria AS, Hatami P. Adherence to the Mediterranean diet in patients with psoriasis and its relationship with the severity of the disease: a case-control study. Health Sci Rep. 2024, 7:e70049. 10.1002\/hsr2.70049","journal-title":"Health Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.51405","article-title":"Guselkumab, a novel monoclonal antibody inhibitor of the p19 subunit of IL-23, for psoriatic arthritis and plaque psoriasis: a review of its mechanism, use, and clinical effectiveness","volume":"15","author":"Kerut CK","year":"2023","unstructured":"Kerut CK, Wagner MJ, Daniel CP, et al.. Guselkumab, a novel monoclonal antibody inhibitor of the p19 subunit of IL-23, for psoriatic arthritis and plaque psoriasis: a review of its mechanism, use, and clinical effectiveness. Cureus. 2023, 15:e51405. 10.7759\/cureus.51405","journal-title":"Cureus"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52139","article-title":"Atypical mycobacterial infection mimicking psoriasis in an elderly patient: diagnostic challenges and management","volume":"16","author":"Arshad M","year":"2024","unstructured":"Arshad M, Kumar A, Ur Rehman MS, Tito Rodriguez PR, Varrassi G. Atypical mycobacterial infection mimicking psoriasis in an elderly patient: diagnostic challenges and management. Cureus. 2024, 16:e52139. 10.7759\/cureus.52139","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/331107-emerging-novel-therapies-for-the-treatment-of-psoriasis-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T14:57:33Z","timestamp":1740581853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/331107-emerging-novel-therapies-for-the-treatment-of-psoriasis-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.79693","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}